Neutra logo

Neutra(OTC) NTRR

Market Cap$291.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-100%
5 Year-97%
1 Year-50%
1 Month-33%
$0.00
-50.00%
-0.00Today
Neutra last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-16
Neutra stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9,900%USD 0.002026-10-09
1 month-33.33%USD 0.002026-09-15
3 month+0%USD 0.002026-07-17
Year to date+0%USD 0.002025-12-31
1 year-50%USD 0.002025-10-16
3 year-75%USD 0.002023-10-17
5 year-97.3%USD 0.002021-10-15
Since inception-100%USD 1,300.002011-10-13

Neutra Financials at a Glance

Market Cap

$291.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.29M

Net Income (TTM)

$992.90K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-17.36 (Low)

Price

$0.00

Volume

1,140,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

NTRR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neutra

Neutra Corp. is a biotechnology company focused on the research, development, and provision of hemp-derived nutraceuticals. Established in 2011 and headquartered in Sugar Land, Texas, the company offers a range of health and wellness products, including CBD-infused sports creams.

Products and Services
  • CBD-infused sports creams designed for pain relief and recovery
  • Health and wellness products leveraging hemp-derived ingredients
  • Research and development in the nutraceutical sector
Growth Outlook
  • Recent quarterly revenue increased to $384,220, showing upward momentum
  • Gross profit margin improved to 46.16% in Q2 2026
  • Operating income ratio reached -2.87%, indicating potential for future profitability
Financial Highlights
  • Trailing twelve months (TTM) revenue of $1,388,000 reflects strong sales performance
  • Net income for Q1 2026 was $84,505, marking a significant turnaround
  • Cash flow from operating activities was $65,283 in Q1 2026, indicating positive cash generation
Neutra Corp. operates in a rapidly growing sector, capitalizing on the increasing demand for hemp-derived products. The company's recent financial performance demonstrates a positive trend, with notable improvements in revenue and profitability metrics. The upward trajectory in gross profit margin and operating income ratio suggests that Neutra Corp. is positioning itself for future growth. With a focus on innovative products and a commitment to research and development, the company is well-placed to capture market opportunities in the health and wellness industry.
AI Generated • Sep 20, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

15

CEO

Sydney Jim

Website

www.neutrainc.com

Headquarters

Houston, TX 77042, US

NTRR Financials

Key Financial Metrics (TTM)

Gross Margin

70.77%

Operating Margin

83.15%

Net Income Margin

77.04%

Return on Equity

-179.36%

Return on Capital

N/A

Return on Assets

423.83%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$291.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.92B

Volume

1.14M

Avg. Volume

2.83M

Financials (TTM)

Gross Profit

$912.18K

Operating Income

$1.07M

EBITDA

$1.08M

Operating Cash Flow

$35.50K

Capital Expenditure

-$37.51K

Free Cash Flow

-$2.01K

Cash & ST Invst.

$76.53K

Total Debt

$115.20K

Neutra Performance Analysis

Neutra annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-01-31USD 67,996-26.1%
20242024-01-31USD 39,534-41.9%
20252025-01-31USD 790,0681898.5%
20262026-01-31USD 1,023,50829.5%
Neutra sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42026-01-31-43.2%
Q42026-01-31-88.9%
Q12026-04-3076.4%
Q22026-07-318.9%
Neutra annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-01-31USD -0.00-25.0%
20242024-01-31USD -0.00-66.7%
20252025-01-31USD -0.000.0%
20262026-01-31USD 0.00N/A
Neutra sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42026-01-31N/A
Q42026-01-31N/A
Q12026-04-30-100.0%
Q22026-07-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2027YOY CHG

Revenue

$384.22K

+41.5%

Gross Profit

$177.37K

+9.3%

Gross Margin

46.16%

N/A

Market Cap

$291.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$19.45K

N/A

Employees

15

N/A

Net Income

-$14.79K

-185.2%

EBITDA

-$9.76K

-141.9%

Quarterly Fundamentals

Name
Q2 2027YOY CHG

Total Cash

$76.53K

+50.4%

Total Debt

$115.20K

-48.0%

Accounts Receivable

$72.36K

+11.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$115.20K

-48.0%

Return on Assets

4.24%

N/A

Return on Invested Capital

-6.22%

N/A

Free Cash Flow

-$72.41K

-725.3%

Operating Cash Flow

-$27.70K

-339.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRZMMarizyme, Inc.
$0.00+0.00%
ORGSOrgenesis Inc.
$0.06+0.00%
BPTHBio-Path Holdings, Inc.
$0.00+0.00%
CATVOpus Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$10.64-11.41%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$49.23+12.81%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.90+7.64%

Questions About NTRR

What is the current price of Neutra?

Neutra is trading at $0.00 per share.

What is the 52-week range for Neutra?

Over the past 52 weeks, Neutra has traded between $0.00 and $0.00.

How much debt does Neutra have?

As of the most recent reporting period, Neutra reported total debt of $115.20K.

How much cash does Neutra have on hand?

Neutra reported $76.53K in cash and cash equivalents in its most recent financial results.

What is Neutra’s dividend yield?

Neutra does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services